Literature DB >> 1330822

Purification and characterization of macrolide 2'-phosphotransferase type II from a strain of Escherichia coli highly resistant to macrolide antibiotics.

M Kono1, K O'Hara, T Ebisu.   

Abstract

The resistance mechanism of Escherichia coli BM2506 to macrolides was found to be due to inactivation. Inactivated oleandomycin was identified as oleandomycin 2'-phosphate by thin-layer chromatography. A new type of macrolide-phosphorylating enzyme, macrolide 2'-phosphotransferase type II (MPH(2')II), was detected, purified 95-fold and its enzymological properties investigated. MPH(2')II was a constitutive intracellular enzyme which showed high levels of activity with both 14-member-ring and 16-member-ring macrolides. The optimum pH for the inactivation of oleandomycin was 8.2 and the optimum temperature of the reaction was 40 degrees C. Enzyme activity was lost by heat treatment at 60 degrees C for 1 min. The isoelectric point and M(r) of the enzyme were 5.3 and 48,000, respectively. Purine nucleotides, such as ITP, GTP and ATP, were effective as cofactors in the inactivation of macrolides. An inhibitory effect of iodine, EDTA, or divalent cations on MPH(2')II activity was observed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1330822     DOI: 10.1016/0378-1097(92)90369-y

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  17 in total

1.  Decreased azithromycin susceptibility of Neisseria gonorrhoeae due to mtrR mutations.

Authors:  L Zarantonelli; G Borthagaray; E H Lee; W M Shafer
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

2.  Identification of functional amino acids in the macrolide 2'-phosphotransferase II.

Authors:  K Taniguchi; A Nakamura; K Tsurubuchi; A Ishii; K O'Hara; T Sawai
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

3.  Detection and characterization of a macrolide 2'-phosphotransferase from a Pseudomonas aeruginosa clinical isolate.

Authors:  A Nakamura; I Miyakozawa; K Nakazawa; K O-Hara; T Sawai
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

4.  Prevalence and mechanism of resistance to antimicrobial agents in group G streptococcal isolates from China.

Authors:  Jun Yin; Sangjie Yu; Xiaorong Liu; Ye Li; Wei Gao; Xiang Ma; Yonghong Yang
Journal:  Antimicrob Agents Chemother       Date:  2010-10-18       Impact factor: 5.191

Review 5.  The macrolide antibiotic renaissance.

Authors:  George P Dinos
Journal:  Br J Pharmacol       Date:  2017-08-10       Impact factor: 8.739

6.  Streptothricin biosynthesis is catalyzed by enzymes related to nonribosomal peptide bond formation.

Authors:  M A Fernández-Moreno; C Vallín; F Malpartida
Journal:  J Bacteriol       Date:  1997-11       Impact factor: 3.490

Review 7.  Resistance to Macrolide Antibiotics in Public Health Pathogens.

Authors:  Corey Fyfe; Trudy H Grossman; Kathy Kerstein; Joyce Sutcliffe
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

8.  Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides.

Authors:  L Wondrack; M Massa; B V Yang; J Sutcliffe
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

9.  Reaction of roxithromycin and clarithromycin with macrolide-inactivating enzymes from highly erythromycin-resistant Escherichia coli.

Authors:  K O'Hara; K Yamamoto
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

10.  Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system.

Authors:  J Sutcliffe; A Tait-Kamradt; L Wondrack
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.